SenesTech Q3 revenue misses estimates

SenesTech

10/11/2025 21:21

Overview

SenesTech Q3 revenue grows 43% yr/yr but misses analyst expectations

Adjusted EBITDA loss improves

Evolve product sales grow 77% yr/yr, driving revenue growth

Outlook

Company expects accelerated growth across e-commerce sites

Company anticipates additional municipal deployments underway or planned

SenesTech intends to pursue profitable growth moving forward

Result Drivers

EVOLVE PRODUCT SALES - Evolve Rodent Birth Control products grew 77% yr/yr, now 85% of total revenue

E-COMMERCE GROWTH - E-commerce revenue increased 55% yr/yr, driven by growth in Amazon sales

MUNICIPAL DEPLOYMENT - Municipal revenue grew 139% yr/yr due to expanded deployments in NYC and Chicago

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Miss
$690,000
$730,000 (1 Analyst)
Q3 Net Income
Beat
-$1.30 mln
-$1.64 mln (1 Analyst)
Q3 Income From Operations
Beat
-$1.35 mln
-$1.58 mln (1 Analyst)
Q3 Basic EPS
-$0.28
Q3 Gross Profit
$433,000
Q3 Operating Expenses
$1.78 mln


Analyst Coverage

The one available analyst rating on the shares is "buy"

The average consensus recommendation for the agricultural chemicals peer group is "buy"

Wall Street's median 12-month price target for Senestech Inc is $10.00, about 66.1% above its November 7 closing price of $3.39

Press Release: ID:nPn8x94Bva

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)